{
    "2019-12-26": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Zacks.com featured highlights include: Genesco, Target, Eli Lilly, Pan American and ChannelAdvisor",
                "features": {
                    "keywords": [
                        "Genesco",
                        "Target",
                        "Eli Lilly",
                        "Pan American",
                        "ChannelAdvisor"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "pharmaceuticals",
                        "technology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Moving Average Crossover Alert: Eli Lilly and Company",
                "features": {
                    "keywords": [
                        "Moving Average",
                        "Crossover",
                        "Eli Lilly"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "Incyte (INCY) Surges 44% YTD on Jakafi's Strong Performance",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Jakafi",
                        "Strong Performance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-18",
                "original_text": "Pharma Companies Are Rushing to Treat a Little-Known Liver Disease. Investors Should Be Skeptical.",
                "features": {
                    "keywords": [
                        "Pharma Companies",
                        "Liver Disease",
                        "Skeptical"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}